955
Participants
Start Date
June 11, 2019
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Dupilumab SAR231893 (REGN668)
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous injection"
Investigational Site Number : 1580014, Taipei
Investigational Site Number : 1580015, Taoyuan
Investigational Site Number : 0560003, Jette
Investigational Site Number : 0560002, Brussels
Investigational Site Number : 0400001, Vienna
Investigational Site Number : 0360002, Kogarah
Investigational Site Number : 0360005, Kogarah
Investigational Site Number : 0400002, Maria Enzersdorf
Investigational Site Number : 0560007, Edegem
Investigational Site Number : 0560008, Leuven
Investigational Site Number : 0360001, Carlton
Investigational Site Number : 0560001, Leige
Investigational Site Number : 0400004, Linz
Investigational Site Number : 0360003, Woolloongabba
Investigational Site Number : 0560004, Namur
Investigational Site Number : 0360004, Bedford Park
Investigational Site Number : 5780001, Bodø
Investigational Site Number : 0400005, Graz
Investigational Site Number : 0560006, Roeselare
Investigational Site Number : 0560010, Ghent
Investigational Site Number : 3800016, Torino
Investigational Site Number : 1700008, Bogotá
Investigational Site Number : 7240008, Santiago de Compostela
Investigational Site Number : 3000002, Athens
Investigational Site Number : 3800008, Genova
Investigational Site Number : 7240021, Granada
Investigational Site Number : 3760006, Afula
Investigational Site Number : 3800004, Milan
Investigational Site Number : 6820001, Jeddah
Investigational Site Number : 3800007, Brescia
Investigational Site Number : 2500001, Valence
Investigational Site Number : 7240016, Madrid
Investigational Site Number : 7240007, Madrid
Investigational Site Number : 7240006, Madrid
Investigational Site Number : 7240010, Madrid
Investigational Site Number : 7240001, Madrid
Investigational Site Number : 7240012, Majadahonda
Investigational Site Number : 3760005, Haifa
Investigational Site Number : 2500002, Toulouse
Investigational Site Number : 6820013, Dammam
Investigational Site Number : 2500003, Bordeaux
Investigational Site Number : 7240002, Oviedo
Investigational Site Number : 7240011, Santullano de Mieres
Investigational Site Number : 2500009, Montpellier
Investigational Site Number : 7840002, Abu Dhabi
Investigational Site Number : 7240004, Las Palmas de Gran Canaria
Investigational Site Number : 2030001, Ústí nad Labem
Investigational Site Number : 1580011, Taichung
Investigational Site Number : 4840001, Guadalajara
Investigational Site Number : 7240019, Bilbao
Investigational Site Number : 7240017, Barakaldo
Investigational Site Number : 2030008, Hradec Králové
Investigational Site Number : 3000003, Thessaloniki
Investigational Site Number : 3800010, Pisa
Investigational Site Number : 3000001, Thessaloniki
Investigational Site Number : 3800009, Torrette Di Ancona
Investigational Site Number : 3800015, L’Aquila
Investigational Site Number : 2460002, Kokkola
Investigational Site Number : 2500006, Pierre-Bénite
Investigational Site Number : 3800012, Bari
Investigational Site Number : 2030003, Ostrava - Poruba
Investigational Site Number : 2500010, Rouen
Investigational Site Number : 3760003, Rehovot
Investigational Site Number : 2030006, Olomouc
Investigational Site Number : 3800001, Napoli
Investigational Site Number : 2500004, Auxerre
Investigational Site Number : 3800018, Palermo
Investigational Site Number : 4140001, Sulaibikat
Investigational Site Number : 3760002, Jerusalem
Investigational Site Number : 2500011, Antony
Investigational Site Number : 2500005, Saint-Mandé Cedex
Investigational Site Number : 1700012, Bogotá
Investigational Site Number : 6430001, Moscow
Investigational Site Number : 6430002, Moscow
Investigational Site Number : 6430004, Saint Petersburg
Investigational Site Number : 1580012, Kaohsiung City
Investigational Site Number : 3760001, Haifa
Investigational Site Number : 3760004, Ramat Gan
Investigational Site Number : 0320013, Pilar
Investigational Site Number : 0320012, Rosario
Investigational Site Number : 0320011, Ciudad Autonoma Bs As
Investigational Site Number : 1700011, Medellín
Investigational Site Number : 2030004, Pilsen
Investigational Site Number : 2030005, Prague
Investigational Site Number : 2030002, Prague
Investigational Site Number : 3800017, Terracina
Investigational Site Number : 3800003, Rome
Investigational Site Number : 3800011, Rome
Investigational Site Number : 3800013, Cagliari
Investigational Site Number : 3800005, Roma
Investigational Site Number : 3920004, Nagakute-shi
Investigational Site Number : 3920015, Obihiro-shi
Investigational Site Number : 3920006, Sapporo
Investigational Site Number : 3920011, Hirakata-shi
Investigational Site Number : 3920008, Koshigaya-shi
Investigational Site Number : 3920005, Shimotsuga-gun
Investigational Site Number : 3920003, Itabashi-ku
Investigational Site Number : 3920022, Amagasaki-shi
Investigational Site Number : 3920002, Habikino-shi
Investigational Site Number : 3920014, Hamamatsu
Investigational Site Number : 3920025, Kyoto
Investigational Site Number : 3920013, Marugame-shi
Investigational Site Number : 3920012, Minokamo-shi
Investigational Site Number : 3920001, Nagoya
Investigational Site Number : 3920010, Setagaya-ku
Investigational Site Number : 3920020, Yokohama
Investigational Site Number : 5280002, Bergen op Zoom
Investigational Site Number : 5780002, Bergen
Investigational Site Number : 6200003, Coimbra
Investigational Site Number : 6200002, Lisbon
Investigational Site Number : 6200004, Porto
Investigational Site Number : 6200001, Vila Nova de Gaia
Investigational Site Number : 7240009, Barcelona
Investigational Site Number : 7240014, Barcelona
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY